This research was approved by the Research Ethics Committee of the Federal University of Rio Grande do Norte, with protocol number 3.434.350 on 3 July 2019. Participants will be informed of the study objectives, its risks and benefits and when eligible for inclusion, if they agree to participate, must sign the informed consent before the study begins. They will be free to abandon the study at any time without the obligation to give any explanation.
There will be prior contact with individuals through social networks, when all information about the study will be presented as well as the Resolution No 466/2012 of the Brazilian National Health Council of 2012, which provides guidelines and standards for research involving human participants. In case any negative effects occur, participants who suffer harm from trial participation will receive physical assistance according to the injury. The study results will be disseminated to participants through social networks and will be submitted to peer-reviewed journals and scientific meetings.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.